In this retrospective cohort analysis, researchers aimed to identify key predictors of trial enrollment among cancer patients.
Final analysis of fixed-duration ibrutinib + venetoclax for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in the phase 2 CAPTIVATE study. Preliminary safety and efficacy data of ...
Can presepsin improve risk stratification in severe UTI? This study shows it outperforms standard biomarkers for mortality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback